Vertes V
Postgrad Med J. 1984;60 Suppl 3:56-8.
Poor results from orthodox diets for the obese have emphasized the need for suitable alternatives such as very low calorie diets (VLCD). These have now been in use for some ten years and their advantages and pitfalls are well known. Initial investigations were based on the use of total fasting and examining the significance of protein supplementation during therapeutic starvation. Subsequent studies employed ordinary food stuffs as the protein source but included no carbohydrate. Others developed formula diets which involved the use of both protein and carbohydrate. In the U.S.A. diets such as these are either monitored by the medical profession or in some instances sold directly to the public. In these connections two areas of concern have emerged. One is the ability of patients to maintain weight loss and most importantly, the safety of the programme itself. It is now well established that unless some follow-up support is made available patients will not be stabilized at the reduced weight level. The use of behaviour modification, increased physical activity and the concept of free and fixed calories offers the hope of a more complete answer to weight control. The safety of VLCD became a cause for concern when liquid protein sold over the counter was associated with a number of deaths for which other causes could not be determined. Subsequent monitoring has indicated that where patients are maintained on high quality protein supplement the potentially lethal arrhythmias associated with liquid protein are not seen. On the basis of clinical experience in over 4000 patients it is felt that three factors are necessary for any programme to be maximally safe and efficient. These elements are proper patient selection, high quality supplement and proper patient monitoring.
传统的肥胖症饮食疗法效果不佳,这凸显了采用合适替代方法的必要性,比如极低热量饮食(VLCD)。这类饮食疗法目前已使用了约十年,其优缺点广为人知。最初的研究基于完全禁食,并探究治疗性饥饿期间补充蛋白质的重要性。后续研究采用普通食物作为蛋白质来源,但不含碳水化合物。其他研究则开发了同时包含蛋白质和碳水化合物的配方饮食。在美国,这类饮食要么由医疗专业人员进行监测,要么在某些情况下直接向公众销售。在这方面出现了两个令人担忧的问题。一是患者维持体重减轻的能力,最重要的是该方案本身的安全性。现在已经明确,除非提供一些后续支持,否则患者无法在减轻后的体重水平上保持稳定。采用行为矫正、增加体育活动以及自由热量和固定热量的概念,有望为体重控制提供更全面的解决方案。当非处方销售的液体蛋白与一些无法确定其他死因的死亡病例相关联时,VLCD的安全性就成了令人担忧的问题。后续监测表明,若患者持续服用高质量蛋白质补充剂,就不会出现与液体蛋白相关的潜在致命心律失常。根据对4000多名患者的临床经验,人们认为任何方案要想达到最大程度的安全和有效,都需要三个因素。这些要素是正确的患者选择、高质量的补充剂以及对患者的适当监测。